Invitation to presentation of Flerie’s Q1 2026 interim report

Non Regulatory

interim report for the first quarter 2026 on Wednesday April 15 at 08:00 CEST. The company will host a live presentation the same day at 11:00 CEST. The call will be hosted by Ted Fjällman (CEO) and Cecilia Stureborg von Schéele (CFO). The presentation will be held in English and include a Q&A session.

Date and time: Wednesday, April 15, at 11:00 CEST.

If you wish to participate via webcast please register via the link below. Please note that it may take a few minutes to receive the confirmation e-mail with the Teams link following registration.

https://events.teams.microsoft.com/event/ea70e333-5a2c-4de4-bc53-b85b569db1ea@8a6f565d-42e1-4b27-93d3-51ae5cf1e4a2

If you experience any issues with the registration in Teams, please contact: contact@flerie.com.

To ask a question during the Q&A session, please click ‘raise your hand’. Your microphone will be enabled when it’s your turn.

For more information:
Ted Fjällman, CEO
Email: ir@flerie.com

Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com

Attachments
Invitation to presentation of Flerie’s Q1 2026 interim report

Documents